Unicycive Therapeutics (UNCY) Other financing activities (2021 - 2025)

Unicycive Therapeutics (UNCY) has 3 years of Other financing activities data on file, last reported at $1.3 million in Q2 2025.

• Quarterly Other financing activities changed N/A year-over-year to $1.3 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (up 139.23% YoY) and the FY2025 annual result came in at $1.5 million, up 139.23% from the prior year.
• Other financing activities improved to $1.3 million in Q2 2025, from $160000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $22.2 million in Q3 2021 to a low of -$3.8 million in Q1 2024.
• A 3-year average of $4.0 million and a median of $160000.0 in 2025 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 104.2% in 2025, down 104.2% in 2025.
• Tracing UNCY's Other financing activities over 3 years: stood at $22.2 million in 2021, then sank by 117.21% to -$3.8 million in 2024, then soared by 135.04% to $1.3 million in 2025.
• The last three Other financing activities figures came in at $1.3 million (Q2 2025), $160000.0 (Q1 2025), and -$3.8 million (Q1 2024), per Business Quant data.